Grunenthal GmbH - Company Profile
Powered by 
All the sales intelligence you need on Grunenthal GmbH in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Grunenthal GmbH fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Grunenthal GmbH.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Grunenthal GmbH patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP3630074B1 | Grant | Multipartikuläre orale darreichungsform mit verlängerter freisetzung von tapentadol | A61K31/137; A61K9/0053; A61K9/16; A61K9/2054; A61K9/2866; A61K9/5047; A61K9/5078; A61P29/02 | October 25, 2023 |
| EP3868739C0 | Grant | Verfahren zur herstellung von (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-phenol | B01J25/02; C07B57/00; C07C211/27; C07C211/28; C07C213/00; C07C213/08; C07C215/54; C07C217/62; C07C217/72; C07C221/00; C07C225/10 | October 04, 2023 |
| EP3868739B1 | Grant | Verfahren zur herstellung von (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-phenol | B01J25/02; C07B57/00; C07C211/27; C07C211/28; C07C213/00; C07C213/08; C07C215/54; C07C217/62; C07C217/72; C07C221/00; C07C225/10 | October 04, 2023 |
| US20230303573A1 | Application | 3-((Hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives | A61P25/00; A61P25/04; A61P25/30; A61P29/00; C07D235/02; C07D401/02; C07D401/04; C07D401/14; C07D403/04; C07D403/14; C07D405/02; C07D405/06; C07D405/14; C07D409/04; C07D409/14; C07D413/02; C07D413/14; C07D417/04; C07D471/04; C07D487/04 | September 28, 2023 |
| CA3015420C | Grant | Titration of cebranopadol | A61K31/407; A61P29/00 | September 26, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer